INFORM2 Exploratory Multinational Phase I/II Combination Study of Nivolumab and Entinostat in Children and Adolescents with Refractory High-Risk Malignancies: INFORM2 NivEnt.Cornelis Martinus van Tilburg,Ruth Witt,Kristian W. Pajtler,Plass Christoph,Isabel Poschke,Michael Platten,Inga Harting,Oliver Sedlaczek,Angelika Freitag, David Meyrath,Lenka Taylor,Gnana Prakash Balasubramanian,Natalie Jaeger,Elke Pfaff,Barbara Christine Worst,Till Milde,Stefan M. Pfister,David T. W. Jones,Annette Kopp-Schneider,Olaf WittJOURNAL OF CLINICAL ONCOLOGY（2019）引用 5|浏览76AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
